| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |